HAIXI PHARMA (02637): Lin Huiyi Appointed as Joint Company Secretary

Stock News11-21

HAIXI PHARMA (02637) announced that Ms. Chen Xiaolin has resigned from her positions as (i) Joint Company Secretary, (ii) Authorized Representative under Rule 3.05 of the Hong Kong Stock Exchange Listing Rules, (iii) Authorized Representative under Part 16 of the Companies Ordinance (Chapter 622 of Hong Kong Law), and (iv) Authorized Person to receive legal documents and notices on behalf of the company in Hong Kong under Rule 19A.13(2) of the Listing Rules, effective from November 21, 2025. Ms. Lin Huiyi has been appointed as Joint Company Secretary, Authorized Representative, and Legal Process Agent, effective from the same date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1147810173?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-21 16:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147810173","market":"nz","top_or_hot":-1,"title":"HAIXI PHARMA (02637): Lin Huiyi Appointed as Joint Company Secretary","media":"Stock News","content":"<p>HAIXI PHARMA (02637) announced that Ms. Chen Xiaolin has resigned from her positions as (i) Joint Company Secretary, (ii) Authorized Representative under Rule 3.05 of the Hong Kong Stock Exchange Listing Rules, (iii) Authorized Representative under Part 16 of the Companies Ordinance (Chapter 622 of Hong Kong Law), and (iv) Authorized Person to receive legal documents and notices on behalf of the company in Hong Kong under Rule 19A.13(2) of the Listing Rules, effective from November 21, 2025. Ms. Lin Huiyi has been appointed as Joint Company Secretary, Authorized Representative, and Legal Process Agent, effective from the same date.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HAIXI PHARMA (02637): Lin Huiyi Appointed as Joint Company Secretary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHAIXI PHARMA (02637): Lin Huiyi Appointed as Joint Company Secretary\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-21 16:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HAIXI PHARMA (02637) announced that Ms. Chen Xiaolin has resigned from her positions as (i) Joint Company Secretary, (ii) Authorized Representative under Rule 3.05 of the Hong Kong Stock Exchange Listing Rules, (iii) Authorized Representative under Part 16 of the Companies Ordinance (Chapter 622 of Hong Kong Law), and (iv) Authorized Person to receive legal documents and notices on behalf of the company in Hong Kong under Rule 19A.13(2) of the Listing Rules, effective from November 21, 2025. Ms. Lin Huiyi has been appointed as Joint Company Secretary, Authorized Representative, and Legal Process Agent, effective from the same date.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02637","symbol_name":"海西新药","start_time":0,"source_url":"","article_id":"1147810173","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147810173","pubTimestamp":1763714422,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"HAIXI PHARMA (02637) announced that Ms. Chen Xiaolin has resigned from her positions as (i) Joint Company Secretary, (ii) Authorized Representative under Rule 3.05 of the Hong Kong Stock Exchange...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02637":"海西新药","BK1191":"制药"},"translate_title":"海西药业(02637)：林慧仪获委任为联席公司秘书","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02637":1},"content_text":"HAIXI PHARMA (02637) announced that Ms. Chen Xiaolin has resigned from her positions as (i) Joint Company Secretary, (ii) Authorized Representative under Rule 3.05 of the Hong Kong Stock Exchange Listing Rules, (iii) Authorized Representative under Part 16 of the Companies Ordinance (Chapter 622 of Hong Kong Law), and (iv) Authorized Person to receive legal documents and notices on behalf of the company in Hong Kong under Rule 19A.13(2) of the Listing Rules, effective from November 21, 2025. Ms. Lin Huiyi has been appointed as Joint Company Secretary, Authorized Representative, and Legal Process Agent, effective from the same date.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1147810173","isCrawlerRequest":true}